Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes

OBJECTIVE: In the 2018 ATN framework, Alzheimer's neurodegenerative biomarkers comprised cerebrospinal fluid (CSF) total tau, (18)F‐fluorodeoxyglucose‐positron emission tomography, and brain atrophy. We aimed to assess the clinical outcomes of having discordant Alzheimer's neurodegenerativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yu, Li, Hong‐Qi, Tan, Lin, Chen, Shi‐Dong, Yang, Yu‐Xiang, Ma, Ya‐Hui, Zuo, Chuan‐Tao, Dong, Qiang, Tan, Lan, Yu, Jin‐Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545611/
https://www.ncbi.nlm.nih.gov/pubmed/32949193
http://dx.doi.org/10.1002/acn3.51196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545611/
https://www.ncbi.nlm.nih.gov/pubmed/32949193
http://dx.doi.org/10.1002/acn3.51196

Ejemplares similares